TNFRSF17 and neoplasm: Taken together with the results of our in vitro experiments, tan-CAR T cells promote the successful elimination of tumor cells that express either CD19, BCMA, or both; our tan-CAR T cells demonstrate high antigen specificity and in vivo efficacy that is comparable to conventional those of single scFv-CAR T cells.